Revenio Group Corporation, Managers’ transactions, August 5, 2022 at 5.30 p.m. (EEST)

 Revenio Group Oyj: Managers' Transactions – Robin Pulkkinen
____________________________________________

Person subject to the notification requirement
Name: Robin Pulkkinen
Position: Chief Financial Officer
Issuer: Revenio Group Oyj
LEI: 743700I27E0FWSXLKK04
Notification type: INITIAL NOTIFICATION
Reference number: 18240/7/6
____________________________________________

Transaction date: 2022-08-04
Venue: NASDAQ HELSINKI LTD (XHEL)
Instrument type: SHARE
ISIN: FI0009010912
Nature of the transaction: DISPOSAL

Transaction details
(1): Volume: 200 Unit price: 53 EUR
(2): Volume: 505 Unit price: 54.6 EUR
(3): Volume: 250 Unit price: 53.2 EUR
(4): Volume: 200 Unit price: 55 EUR
(5): Volume: 200 Unit price: 54 EUR
Aggregated transactions
(5): Volume: 1355 Volume weighted average price: 54.07601 EUR

For further information, please contact
CFO Robin Pulkkinen, tel. +358 50 505 9932
robin.pulkkinen@revenio.fi
www.revenio.fi

Distribution
Nasdaq Helsinki Ltd
Main media
www.revenio.fi

Revenio Group in brief
Revenio is a leading company in the global market for ophthalmological devices and software solutions. Revenio’s ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), fundus imaging devices, and perimeters as well as clinical software under the iCare brand. iCare is a trusted partner in ophthalmic diagnostics, offering physicians fast, easy-to-use, and reliable tools for the diagnosis of glaucoma, diabetic retinopathy, and macular degeneration (AMD). iCare Solutions provide digital clinical tools that drive greater efficiency and enhance quality in eye care.

In 2021, the Group’s net sales totaled EUR 78.8 million, with an operating profit of EUR 22.1 million. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V.

Attachments

Revenio Group Corporation: Managers' Transactions – Robin Pulkkinen

© Modular Finance, source Nordic Press Releases